Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2000
09/26/2000US6123959 Phospholipids, and competitive inhibitor(s) including arbutin of an enzyme for the synthesis of melanin, tyrosinase and non-competitive inhibitor(s) of tyrosinase selected from specified substituted 4-oxo-chromene compounds
09/26/2000US6123956 Methods for universally distributing therapeutic agents to the brain
09/26/2000US6123953 Synergistic topical mixture of a 1,2-alkanediol of given formula and a clathrate glyceryl poly(meth)acrylate gel of given viscosity comprising 20-90% glycerin, 10-80% water and 0.1-5% weight of poly(meth)acrylate; preventing mastitis
09/26/2000US6123946 Hygienic bag and preparation thereof
09/26/2000US6123936 Methods and compositions for the dry powder formulation of interferons
09/26/2000US6123924 Pressurized aerosol inhalation compositions
09/26/2000US6123922 Resilient deformable microballoons for echographic imaging
09/26/2000US6123861 Fabrication of microchip drug delivery devices
09/26/2000US6123700 Method and apparatus for sealing implantable membrane encapsulation devices
09/26/2000CA2270306C Pharmaceutical compositions comprising co-micronized fenofibrate
09/26/2000CA2253769C Pharmaceutical compositions comprising fenofibrate
09/26/2000CA2190011C Method for reduction of headache pain
09/26/2000CA2181990C Rapidly dissolving oral dosage form
09/26/2000CA2150682C Composition, apparatus and method for providing a supply of water-based cool mixture
09/26/2000CA2126244C Suspension aerosol formulations
09/24/2000CA2298236A1 Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
09/21/2000WO2000055192A2 Hemocyanin and nucleic acid sequence coding for the same
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055072A2 Aerosol metering valve
09/21/2000WO2000054866A1 Responsive gels and methods of use thereof
09/21/2000WO2000054838A1 Calcium-containing composition
09/21/2000WO2000054812A1 Improved composition for oral administration
09/21/2000WO2000054811A1 Medicinal compositions
09/21/2000WO2000054798A1 Antiviral agent in the form of nose drops
09/21/2000WO2000054797A2 Pharmaceutical compositions comprising tgf-beta
09/21/2000WO2000054794A1 Wafer delivery system
09/21/2000WO2000054790A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000WO2000054789A1 Bacterial membrane fractions with adjuvant effect
09/21/2000WO2000054780A2 Corticosteroid formulation
09/21/2000WO2000054779A1 OCULAR THERAPY IN KERATOCONJUCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-$g(b)
09/21/2000WO2000054777A1 Controlled release of sildenafil delivered by sublingual or buccal administration
09/21/2000WO2000054775A1 Stable pharmaceutical application form for paroxetin anhydrate
09/21/2000WO2000054763A2 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000054758A2 Method for delivering benzidine prostaglandins by inhalation
09/21/2000WO2000054754A2 Composition comprising isoquercetin and ascorbic acid in a sustained release form
09/21/2000WO2000054753A2 Novel tablets incorporating isoflavone plant extracts and methods of manufacturing them
09/21/2000WO2000054752A1 Quickly disintegrating tablets and process for producing the same
09/21/2000WO2000054751A1 Method for producing solid dosage forms containing cyclodextrin
09/21/2000WO2000054750A1 Method for correcting disturbance in collagen synthesis and biologically active substance for realising the same
09/21/2000WO2000054749A1 Media in the form of complex dispersions, method for preparing same and uses
09/21/2000WO2000054748A1 Metered dose inhalers with isobutane as propellant
09/21/2000WO2000054747A2 Method for treating dry eye
09/21/2000WO2000054746A1 An improved reversible contraceptive for male and female
09/21/2000WO2000054745A2 Devices and methods for pain management
09/21/2000WO2000054744A1 Device for releasing cosmetic active substances
09/21/2000WO2000054735A1 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use
09/21/2000WO2000054725A1 Method for making pharmaceutical tablets by compression
09/21/2000WO2000027828A3 2,4-disubstituted triazine derivatives with anti hiv activity
09/21/2000WO2000027207A8 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
09/21/2000WO2000025819A9 Enhanced radiation therapy
09/21/2000WO2000021505A3 Composition for the parenteral administration of active agents
09/21/2000WO2000016746A9 Immunogenic liposome compositions
09/21/2000WO2000013662A3 Medicated chewing gum delivery system for nicotine
09/21/2000WO1999039706A9 Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl) ethylenediamine-n, n'-diacetic acid for iron chelating therapy
09/21/2000DE19918105C1 Transdermal patch for administering neuroleptic agent i.e. fluphenazine, flupentixol or triflupromazine, includes matrix layer containing penetration enhancer and hydrocarbon polymer
09/21/2000DE19912502A1 Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung Nanoscale particles, complexes with polynucleotides and their use
09/21/2000DE19912360A1 Strangförmiges Implantat aus resorbierbarem Polymermaterial, Verfahren zu seiner Herstellung und Anwendung in der Chirurgie An extruded implant of resorbable polymer material, process for its preparation and application in surgery
09/21/2000DE19911777A1 Verfahren zur Herstellung von kosmetischen Formulierungen A process for the preparation of cosmetic formulations
09/21/2000DE19911262A1 Vorrichtung zur Abgabe kosmetischer Wirkstoffe A device for delivering cosmetic ingredients
09/21/2000CA2367917A1 Bacterial membrane fractions with adjuvant effect
09/21/2000CA2367850A1 Method for making pharmaceutical tablets by compression
09/21/2000CA2367643A1 Ocular therapy in keratoconjuctivitis sicca using topically applied androgens or tgf-.beta.
09/21/2000CA2367571A1 Responsive gels and methods of use thereof
09/21/2000CA2367409A1 Metering valve
09/21/2000CA2367394A1 Cosmetic active substance delivery means
09/21/2000CA2367391A1 Process for the preparation of cosmetic or pharmaceutical formulations using a micromixer
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367211A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2365451A1 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin
09/21/2000CA2363705A1 Devices and methods for pain management
09/21/2000CA2361503A1 Corticosteroid formulation
09/21/2000CA2332767A1 Dhea composition and method
09/20/2000EP1036783A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
09/20/2000EP1036573A1 Device for delivering drug through skin or mucosa
09/20/2000EP1036563A1 Delayed-release oral formulation of dihydroxy open acid simvastatin and salts and esters thereof
09/20/2000EP1036562A1 Soft-pellet drug and process for the preparation thereof
09/20/2000EP1036561A1 Buccal, non-polar spray
09/20/2000EP1036559A1 Emulsion composition of the type oil-in-water containing an acrylic terpolymer and it's applications in cosmetics
09/20/2000EP1036510A2 Vitamin formulation for cardiovascular health
09/20/2000EP1036057A1 Radio-opaque polymer biomaterials
09/20/2000EP1035891A1 Stereospecific delivery of a drug using electrotransport
09/20/2000EP1035889A1 Device for enhancing transdermal agent flux
09/20/2000EP1035882A1 Automatic liquid injection system and method
09/20/2000EP1035869A1 Chemically and thermally stable norastemizole formulations
09/20/2000EP1035867A1 Transdermal delivery of particulate vaccine compositions
09/20/2000EP1035866A2 Mixed lipopeptide micelles for inducing an immune response and their therapeutic uses
09/20/2000EP1035862A2 Cyclosporin-containing microemulsion preconcentrate composition
09/20/2000EP1035859A1 THE USE OF PHOSPHOLIPID COMPLEXES OF EXTRACTS OF $i(VITIS VINIFERA) AS ANTI-ATHEROSCLEROTIC AGENTS
09/20/2000EP1035857A1 Oral antioxidant preparation comprising selenium and reduced glutathione
09/20/2000EP1035844A1 The use of polyols in combating yeast infection and polyol preparations for said use
09/20/2000EP1035842A1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION
09/20/2000EP1035841A1 Method for producing solid dosing forms
09/20/2000EP1035840A1 Sustained release formulation containing three different types of polymers and tablet formed therefrom
09/20/2000EP1035839A4 Implantable gas propelled beneficial agent delivery device
09/20/2000EP1035839A1 Implantable gas propelled beneficial agent delivery device
09/20/2000EP1035838A1 Pharmaceutical suspension tablet compositions
09/20/2000EP1035837A2 Lipid compositions and their use
09/20/2000EP1035836A1 Improved method for avoiding the degradation of an active principle
1 ... 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 ... 2991